Prostatype Genomics (Sweden) Price Prediction
| PROGEN Stock | SEK 7.50 0.15 1.96% |
Oversold Vs Overbought
24
Oversold | Overbought |
Using Prostatype Genomics hype-based prediction, you can estimate the value of Prostatype Genomics AB from the perspective of Prostatype Genomics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Prostatype Genomics to buy its stock at a price that has no basis in reality. In that case, they are not buying Prostatype because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Prostatype Genomics after-hype prediction price | SEK 7.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prostatype |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prostatype Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Prostatype Genomics After-Hype Price Prediction Density Analysis
As far as predicting the price of Prostatype Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Prostatype Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Prostatype Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Prostatype Genomics Estimiated After-Hype Price Volatility
In the context of predicting Prostatype Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Prostatype Genomics' historical news coverage. Prostatype Genomics' after-hype downside and upside margins for the prediction period are 0.21 and 14.79, respectively. We have considered Prostatype Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Prostatype Genomics is unstable at this time. Analysis and calculation of next after-hype price of Prostatype Genomics is based on 3 months time horizon.
Prostatype Genomics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Prostatype Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prostatype Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Prostatype Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.18 | 7.29 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.50 | 7.50 | 0.00 |
|
Prostatype Genomics Hype Timeline
Prostatype Genomics is at this time traded for 7.50on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Prostatype is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -1.18%. %. The volatility of related hype on Prostatype Genomics is about 0.0%, with the expected price after the next announcement by competition of 7.50. About 13.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.14. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prostatype Genomics recorded a loss per share of 1.22. The entity had not issued any dividends in recent years. The firm had 1000:1 split on the 18th of August 2024. Assuming the 90 days trading horizon the next estimated press release will be within a week. Check out Prostatype Genomics Basic Forecasting Models to cross-verify your projections.Prostatype Genomics Related Hype Analysis
Having access to credible news sources related to Prostatype Genomics' direct competition is more important than ever and may enhance your ability to predict Prostatype Genomics' future price movements. Getting to know how Prostatype Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Prostatype Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SPRINT | Sprint Bioscience AB | 0.00 | 0 per month | 4.22 | 0.09 | 9.88 | (5.81) | 29.57 | |
| STABL | Stayble Therapeutics AB | 0.00 | 0 per month | 0.00 | (0.08) | 10.77 | (8.82) | 36.33 | |
| IZAFE-B | iZafe Group AB | 0.00 | 0 per month | 0.00 | (0.03) | 10.00 | (5.00) | 29.29 | |
| IDOGEN | Idogen AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ZICC | Ziccum AB | 0.00 | 0 per month | 0.00 | (0.21) | 9.75 | (12.38) | 69.22 |
Prostatype Genomics Additional Predictive Modules
Most predictive techniques to examine Prostatype price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Prostatype using various technical indicators. When you analyze Prostatype charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Prostatype Genomics Predictive Indicators
The successful prediction of Prostatype Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Prostatype Genomics AB, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Prostatype Genomics based on analysis of Prostatype Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Prostatype Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Prostatype Genomics's related companies.
Story Coverage note for Prostatype Genomics
The number of cover stories for Prostatype Genomics depends on current market conditions and Prostatype Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Prostatype Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Prostatype Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Prostatype Genomics Short Properties
Prostatype Genomics' future price predictability will typically decrease when Prostatype Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Prostatype Genomics AB often depends not only on the future outlook of the potential Prostatype Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prostatype Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.1 M |
Complementary Tools for Prostatype Stock analysis
When running Prostatype Genomics' price analysis, check to measure Prostatype Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prostatype Genomics is operating at the current time. Most of Prostatype Genomics' value examination focuses on studying past and present price action to predict the probability of Prostatype Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prostatype Genomics' price. Additionally, you may evaluate how the addition of Prostatype Genomics to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |